Richard A Larson Selected Research

Clofarabine (Clolar)

6/2012	Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
12/2007	Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
12/2005	Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Larson Research Topics

Disease

102	Neoplasms (Cancer) 03/2024 - 05/2002
87	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 04/2002
84	Leukemia 01/2023 - 03/2002
46	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 05/2002
32	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 03/2002
25	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2020 - 03/2002
22	Philadelphia Chromosome 09/2022 - 03/2003
21	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 07/2002
15	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 04/2002
13	Myeloid Leukemia (Leukemia, Myelocytic) 03/2018 - 09/2002
11	Infections 10/2021 - 08/2006
10	Acute Promyelocytic Leukemia 01/2022 - 11/2010
8	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 12/2004
8	Blast Crisis (Blast Phase) 05/2013 - 05/2002
7	Residual Neoplasm 01/2021 - 03/2003
7	Thrombocytopenia (Thrombopenia) 10/2019 - 03/2007
5	Lymphoma (Lymphomas) 12/2023 - 04/2004
5	Fatigue 01/2021 - 09/2002
4	Anemia 11/2023 - 04/2008
4	Diarrhea 01/2023 - 07/2009
4	Disease Progression 01/2021 - 03/2007
4	Febrile Neutropenia 01/2021 - 10/2007
4	Cytopenia 10/2018 - 05/2002
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2023 - 06/2007
3	Hemorrhage 03/2017 - 08/2006
3	Prolymphocytic Leukemia 05/2015 - 09/2002
2	Atrial Fibrillation 01/2024 - 10/2021
2	Hypertension (High Blood Pressure) 01/2024 - 10/2021
2	Pathologic Complete Response 12/2021 - 05/2005
2	Hyperbilirubinemia 01/2021 - 10/2005
2	B-Cell Leukemia (Leukemia, B Cell) 01/2021 - 12/2007
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 11/2008
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

33	Imatinib Mesylate (Gleevec)FDA Link 07/2021 - 05/2002
24	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 01/2003
21	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2009
19	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2007
18	fludarabineIBA 01/2023 - 07/2002
13	nilotinib FDA Link 07/2021 - 02/2008
10	Dasatinib (BMS 354825)FDA Link 11/2021 - 05/2007
8	Rituximab (Mabthera)FDA Link 04/2024 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2002
7	midostaurinIBA 01/2022 - 01/2017
7	Alemtuzumab (Campath)FDA Link 01/2020 - 01/2009
7	Alkylating AgentsIBA 01/2011 - 06/2002
6	fms-Like Tyrosine Kinase 3IBA 01/2023 - 01/2017
6	Phosphotransferases (Kinase)IBA 01/2022 - 10/2008
6	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2015 - 11/2004
6	Interferon-alpha (Interferon Alfa)IBA 12/2009 - 03/2003
5	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 05/2002
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 12/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2002
5	bcr-abl Fusion ProteinsIBA 01/2011 - 12/2002
4	Monoclonal AntibodiesIBA 11/2023 - 03/2003
4	Arsenic Trioxide (Trisenox)FDA Link 01/2022 - 11/2010
4	blinatumomabIBA 01/2021 - 01/2016
4	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020 - 06/2010
4	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 08/2005
4	Interleukin-2 (IL2)IBA 04/2014 - 09/2002
4	nelarabine (506U78)FDA Link 10/2012 - 09/2006
4	InterferonsIBA 11/2010 - 01/2003
4	valspodar (PSC 833)IBA 09/2010 - 08/2002
3	ibrutinibIBA 01/2024 - 12/2018
3	Histone Deacetylase InhibitorsIBA 11/2023 - 11/2008
3	Alanine Transaminase (SGPT)IBA 01/2023 - 10/2005
3	pegaspargase (Oncaspar)FDA Link 01/2023 - 05/2007
3	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 12/2004
3	gilteritinibIBA 01/2023 - 10/2019
3	tipifarnib (R115777)IBA 12/2021 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 05/2008
3	romiplostim FDA Link 01/2017 - 01/2010
3	alvocidib (flavopiridol)IBA 05/2015 - 06/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 03/2007
3	Gemtuzumab (Mylotarg)FDA Link 06/2013 - 10/2005
3	Clofarabine (Clolar)FDA Link 06/2012 - 12/2005
3	NucleosidesIBA 09/2006 - 12/2003
3	Etoposide (VP 16)FDA LinkGeneric 01/2005 - 05/2004
2	Bendamustine Hydrochloride FDA Link 04/2024 - 12/2018
2	enasidenibIBA 12/2023 - 01/2020
2	LigandsIBA 10/2023 - 09/2012
2	TransferasesIBA 12/2021 - 12/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 08/2021
2	selinexorIBA 11/2020 - 01/2018
2	AnthracyclinesIBA 01/2018 - 09/2012
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 10/2005

Therapy/Procedure

97	Therapeutics 03/2024 - 03/2002
44	Drug Therapy (Chemotherapy) 12/2023 - 04/2002
11	Cell Transplantation 01/2022 - 01/2009
9	Stem Cell Transplantation 04/2024 - 07/2003
8	Radiotherapy 01/2013 - 04/2002
7	Hematopoietic Stem Cell Transplantation 11/2020 - 10/2005
6	Transplantation 01/2023 - 01/2005
4	Remission Induction 11/2020 - 03/2013
4	Consolidation Chemotherapy 01/2020 - 09/2002
4	Homologous Transplantation 01/2019 - 09/2007
3	Salvage Therapy 12/2019 - 08/2005
3	Induction Chemotherapy 01/2013 - 06/2004
2	Immunotherapy 12/2023 - 10/2008